Back to today’s briefing

Story perspectives

FDA Approves Tenecteplase for Stroke: New Era in Care

3/14/2025

29 5

Summary

Story summary

The US FDA has officially approved tenecteplase (TNKase) for acute ischemic stroke treatment, a significant shift from its previous off-label use. Dr. Yasmin Aziz emphasizes its simpler administration compared to alteplase, while new weight-based dosing guidelines promise to transform clinical practices. Exciting trials are also underway, seeking innovative alternatives in stroke care.

1 of 1

Story summary

The US FDA has officially approved tenecteplase (TNKase) for acute ischemic stroke treatment, a significant shift from its previous off-label use. Dr. Yasmin Aziz emphasizes its simpler administration compared to alteplase, while new weight-based dosing guidelines promise to transform clinical practices. Exciting trials are also underway, seeking innovative alternatives in stroke care.